Jubilant Ingrevia's Stock Sees -5.22% Decline, Outperforms Sector Despite Recent Fall

Jubilant Ingrevia, a midcap pharmaceutical and drugs company, saw a decline of -5.22% in its stock price on October 22, 2024. This underperformance was noted by MarketsMOJO, who has given a 'Hold' call for the stock.

The stock has been on a consecutive fall for the last two days, with a total decline of -8.05% during this period. On October 22, the stock touched an intraday low of Rs 687.6, which is a decrease of -5.96%.

Despite the recent decline, Jubilant Ingrevia's stock is still performing better than the sector, with a difference of -4.46%. However, it is currently trading below its 5-day, 20-day, and 50-day moving averages, while still being higher than its 100-day and 200-day moving averages.

In comparison to the overall market performance, Jubilant Ingrevia's stock has underperformed, with a -4.62% decline in the last 1 day, while the Sensex only saw a -0.31% decrease. Similarly, in the last 1 month, the stock has declined by -8.52%, while the Sensex has only seen a -4.31% decrease.

Overall, Jubilant Ingrevia's stock has seen a recent decline, but it is still performing better than the sector. Investors may want to keep an eye on the stock's performance in the coming days to make informed decisions.